Brief: Immunovia Presents Update On US Market Size For Immray PanCan-D In Familial/Hereditary Risk Group

Immunovia AB (publ)

22/04/2021 06:26

April 22 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA PRESENTS UPDATE ON US MARKET SIZE FOR IMMRAY™
PANCAN-D
IN FAMILIAL/HEREDITARY RISK GROUP
    * NEW ESTIMATIONS SHOW THAT315,000 – 350,000 INDIVIDUALS
HAVE A
FAMILIAL/HEREDITARY RISK FOR PANCREATIC CANCER AND WOULD QUALIFY
TO BE ENROLLED IN PANCREATIC CANCER SURVEILLANCE PROGRAMS
    * UPDATES OF THE GUIDELINES HAS LED THE COMPANY TO
RE-EXAMINE THE
POTENTIAL MARKET SIZE FOR SURVEILLANCE OF HIGH-RISK INDIVIDUALS
IN THE FAMILIAL/HEREDITARY RISK GROUP

Source text for Eikon:  ID:nWkrG9H4x 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))